Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cardiovascular Patient Equipment Supplied In Europe
4 equipment items found
Manufactured by:Bioprojet based inParis, FRANCE
Kengrexal, co-administered with acetylsalicylic acid (ASA), is indicated for the reduction of thrombotic cardiovascular events in adult patients with coronary artery disease having undergone a percutaneous coronary intervention (PCI), who have not received an oral P2Y12 receptor inhibitor prior to the intervention and in whom the oral route for such a ...
Manufactured by:Darnitsa Group based inKyiv, UKRAINE
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol. The primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. Rosuvastatin increases the number of hepatic low-density lipoprotein (LDL) receptors on the cell ...
Manufactured by:Bayer AG based inLeverkusen, GERMANY
Traditionally, many small molecule drugs follow the same basic mechanism of action to treat diseases: They inhibit the function of a target protein that has an active role in a disease. To do so, they require a tractable active binding site to occupy, which will result in protein function inhibition like blocking its enzymatic activity. But traditional small molecules can only block one single ...
by:SOMNOmedics GmbH based inRandersacker, GERMANY
1. Validation according to the ESH-IP 2010 protocol, 2. Against cuff-based method during ergometry, 3. Against cuff-based method over 24 hours, 4. Against cuff-based method during CPAP therapy, 5. Against the Penaz method, 6. Against intra-arterial BP measurement. Imagine being able to see a patient’s cardio-health over 24 hours: Where you can see a continuous, reaction-less beat-to-beat ...